GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.43+0.25 (+7.86%)
Close on Nov 18, 2026Market cap $154.73MP/E –Yield –
GT Biopharma total assets
Total assets on the balance sheet at the end of each period.
GT Biopharma's total assets was $8.11M at Dec 31, 2025. For fiscal 2025 it was $8.11M, up 91.5% from the year before. Over ten years it grew 65.1% a year on average. The highest annual figure on record is $254.37M in fiscal 2017.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.11M | +91.5% |
| FY2024 | Dec 31, 2024 | $4.23M | -70.0% |
| FY2023 | Dec 31, 2023 | $14.11M | -15.7% |
| FY2022 | Dec 31, 2022 | $16.74M | -48.0% |
| FY2021 | Dec 31, 2021 | $32.17M | +468.3% |
| FY2020 | Dec 31, 2020 | $5.66M | +1329.5% |
| FY2019 | Dec 31, 2019 | $396.00K | -98.4% |
| FY2018 | Dec 31, 2018 | $25.40M | -90.0% |
| FY2017 | Dec 31, 2017 | $254.37M | +1017372.0% |
| FY2016 | Dec 31, 2016 | $25.00K | -53.7% |
| FY2015 | Dec 31, 2015 | $54.00K | -93.9% |
| FY2014 | Dec 31, 2014 | $888.00K | +504.1% |
| FY2013 | Dec 31, 2013 | $147.00K | -35.0% |
| FY2012 | Dec 31, 2012 | $226.00K | +75.2% |
| FY2011 | Dec 31, 2011 | $129.00K | -30.3% |
| FY2010 | Dec 31, 2010 | $185.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $8.11M | +19.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.32M | -53.4% |
| Q2 FY2025 | Jun 30, 2025 | $7.12M | -28.1% |
| Q4 FY2024 | Dec 31, 2024 | $4.23M | -70.0% |
| Q3 FY2024 | Sep 30, 2024 | $6.76M | -58.1% |
| Q2 FY2024 | Jun 30, 2024 | $9.27M | -48.9% |
| Q1 FY2024 | Mar 31, 2024 | $9.91M | -50.7% |
| Q4 FY2023 | Dec 31, 2023 | $14.11M | -15.7% |
| Q3 FY2023 | Sep 30, 2023 | $16.15M | -23.4% |
| Q2 FY2023 | Jun 30, 2023 | $18.14M | -24.9% |
| Q1 FY2023 | Mar 31, 2023 | $20.09M | -26.8% |
| Q4 FY2022 | Dec 31, 2022 | $16.74M | -48.0% |
| Q3 FY2022 | Sep 30, 2022 | $21.07M | +272.2% |
| Q2 FY2022 | Jun 30, 2022 | $24.17M | +2535.8% |
| Q1 FY2022 | Mar 31, 2022 | $27.44M | +2481.3% |
| Q4 FY2021 | Dec 31, 2021 | $32.17M | +10804.7% |
| Q4 FY2020 | Dec 31, 2020 | $5.66M | +1329.5% |
| Q3 FY2020 | Sep 30, 2020 | $917.00K | +90.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.06M | -95.9% |
| Q1 FY2020 | Mar 31, 2020 | $295.00K | -98.8% |
| Q4 FY2019 | Dec 31, 2019 | $396.00K | -98.4% |
| Q3 FY2019 | Sep 30, 2019 | $482.00K | -98.2% |
| Q2 FY2019 | Jun 30, 2019 | $25.71M | -89.9% |
| Q1 FY2019 | Mar 31, 2019 | $25.54M | -90.1% |
| Q4 FY2018 | Dec 31, 2018 | $25.40M | -90.0% |
| Q3 FY2018 | Sep 30, 2018 | $26.54M | -89.7% |
| Q2 FY2018 | Jun 30, 2018 | $255.01M | +607076.2% |
| Q1 FY2018 | Mar 31, 2018 | $257.33M | +108023.1% |
| Q4 FY2017 | Dec 31, 2017 | $254.37M | +1017372.0% |
| Q3 FY2017 | Sep 30, 2017 | $256.52M | +160225.0% |
| Q2 FY2017 | Jun 30, 2017 | $42.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $238.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $25.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $160.00K | – |
See a number that looks wrong?